The intravenous iron preparation Rienso (ferumoxytol) has been withdrawn for commercial reasons. Launched in 2012, it was licensed for the treatment of iron deficiency anaemia in patients with chronic kidney disease.
The most up-to-date drug information at your fingertips.
- Get the prescribing support you need.
- Register today for full access to the MIMS database, plus tables and guideline summaries, new and deleted products and consultation tools.
Join us for the MIMS Workshops Respiratory and Allergy...
Hormone doses and costs of HRT preparations.
Widespread false diagnosis of COPD is exposing patients to unnecessary medication risks, study suggests
Patients are being unnecessarily exposed to the adverse...
Compatible test strips for blood glucose meters.